Efficacy and Safety of Spesolimab in Patients with Generalized Pustular Psoriasis: A Subgroup Analysis of Chinese Patients in the Effisayil 1 Trial

• Asıl Yazarlar: Tsen-Fang Tsai (Yazar), Min Zheng (Yazar), Yangfeng Ding (Yazar), Zhiqi Song (Yazar), Quanzhong Liu (Yazar), Ying Chen (Yazar), Hanzhao Hu (Yazar), Jinhua Xu (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Adis, Springer Healthcare, 2023-10-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Abstract Introduction Generalized pustular psoriasis (GPP) is a rare and potentially life-threatening skin disease. The global Effisayil 1 study investigated the efficacy and safety of spesolimab, a humanized monoclonal antibody targeting the IL-36 receptor, in patients experiencing GPP flare. This...